Connor, Clark & Lunn Investment Management (CC&L)’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $97.3K | Sell |
|
|||||
|
2024
Q4 | $171K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $85K | Sell |
|
|||||
|
2022
Q3 | $213K | Sell |
|
|||||
|
2022
Q2 | $300K | Sell |
|
|||||
|
2022
Q1 | $340K | Sell |
|
|||||
|
2021
Q4 | $397K | Buy |
|
|||||
|
2021
Q3 | $544K | Buy |
|
|||||
|
2021
Q2 | $589K | Buy |
|
|||||
|
2021
Q1 | $638K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $237K | Buy |
|